Paper2354591
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D and 1 other. Clin Pharmacokinet, 1990. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis. Papers, record 2354591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2354591
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dialysis Solutions | Major topic |
| Peritoneal Dialysis, Continuous Ambulatory | Major topic |
| Vancomycin | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Dialysis | |
| Female | |
| Half-Life | |
| Humans | |
| Injections, Intraperitoneal | |
| Male | |
| Middle Aged | |
| Models, Biological |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,177,373 | Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy. | Am J Kidney Dis | 1988 | https://conductscience.org/library/papers/3177373 | PubMed |
| 2 | 2,882,244 | Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Report of a working party of the British Society for Antimicrobial Chemotherapy. | Lancet | 1987 | https://conductscience.org/library/papers/2882244 | PubMed |
| 3 | 7,110,474 | Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. | Nephron | 1982 | https://conductscience.org/library/papers/7110474 | PubMed |
| 4 | 3,566,247 | Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3566247 | PubMed |
| 5 | 6,627,823 | Vancomycin kinetics during continuous ambulatory peritoneal dialysis. | Clin Pharmacol Ther | 1983 | https://conductscience.org/library/papers/6627823 | PubMed |
| 6 | 4,004,194 | Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4004194 | PubMed |
| 7 | 3,627,326 | Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis? | Nephron | 1987 | https://conductscience.org/library/papers/3627326 | PubMed |
| 8 | 6,846,332 | Peritonitis in continuous ambulatory peritoneal dialysis patients. | Am J Kidney Dis | 1983 | https://conductscience.org/library/papers/6846332 | PubMed |
| 9 | 3,724,930 | Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. | Nephron | 1986 | https://conductscience.org/library/papers/3724930 | PubMed |
| 10 | 415,661 | Sensitive bioassay for vancomycin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/415661 | PubMed |
| 11 | 718,158 | Safety of oral vancomycin in functionally anephric patients. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/718158 | PubMed |
| 12 | 4,000,335 | Chronic peritoneal dialysis: mechanical and infectious complications. | Nephron | 1985 | https://conductscience.org/library/papers/4000335 | PubMed |
| 13 | 6,732,213 | Pharmacokinetics of vancomycin in patients with various degrees of renal function. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6732213 | PubMed |
| 14 | 7,137,982 | Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7137982 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,896,604 | Intraperitoneally Administered Vancomycin Results in Suboptimal Serum and Peritoneal Effluent Drug Levels in Patients with PD-related Peritonitis. | Indian J Nephrol | 2025 | https://conductscience.org/library/papers/40896604 | PubMed |
| 32,065,053 | Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. | Perit Dial Int | 2020 | https://conductscience.org/library/papers/32065053 | PubMed |
| 24,676,741 | Vancomycin: the tale of the vanquisher and the pyrrhic victory. | Perit Dial Int | 2014 | https://conductscience.org/library/papers/24676741 | PubMed |
| 1,606,789 | Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1606789 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2354591
GET https://conductscience.org/api/papers/v1/2354591/authors